Sponsor

University of Cape Town

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name University of Cape Town appears in 122 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials122
Recruiting shown13
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

60 shown
B. Infantis Supplementation to Improve Immunity in Infants Exposed to HIVNCT05923333 · lead sponsor · 2023-08-11
RECRUITING
Remote Ischaemic Conditioning in STEMI Patients in AFRICANCT04813159 · lead sponsor · 2022-01-12
RECRUITING
Atorvastatin to Reduce Inflammation After Tuberculosis Treatment CompletionNCT04147286 · lead sponsor · 2020-07-14
RECRUITING
The Coach Mpilo Study: Evaluation of a Peer-led Intervention to Promote Engagement in HIV Care for Men Living With HIVNCT07564193 · lead sponsor · 2026-05-11
NOT_YET_RECRUITING
Choice-Based Support for Adults Starting or Restarting Antiretroviral Therapy in Cape Town, South AfricaNCT07439562 · lead sponsor · 2026-02-01
NOT_YET_RECRUITING
B.R.A.I.N in People Living With HIV StudyNCT06466642 · lead sponsor · 2023-01-16
UNKNOWN
Point-of-care Ultrasound Abnormalities in Early Onset PreeclampsiaNCT05662995 · lead sponsor · 2022-11-28
UNKNOWN
Point-of-care Ultrasound Abnormalities in EclampsiaNCT05678062 · lead sponsor · 2022-11-21
UNKNOWN
Evaluating the Impact of Computer-assisted X-ray Diagnosis and Other Triage Tools to Optimise Xpert Orientated Community-based Active Case Finding for TB and COVID-19NCT05220163 · lead sponsor · 2022-02-23
ACTIVE_NOT_RECRUITING
High vs. Standard Dose Rifampicin for Effusive Tuberculous PericarditisNCT04521803 · lead sponsor · 2022-01-10
COMPLETED
Testing New Strategies for Patients Hospitalised With HIV-associated Disseminated TuberculosisNCT04951986 · lead sponsor · 2021-08-11
ACTIVE_NOT_RECRUITING
An Observational Study of Distress, Immune Function, and Pain in HIV.NCT04757987 · lead sponsor · 2021-02-11
COMPLETED
Catalysing the Containment of COVID-19NCT04523090 · lead sponsor · 2020-08-27
TERMINATED
Chloroquine Outpatient Treatment Evaluation for HIV-Covid-19NCT04360759 · lead sponsor · 2020-05-01
WITHDRAWN
Standard Versus Double Dose Dolutegravir in Patients With HIV-associated TuberculosisNCT03851588 · lead sponsor · 2019-12-19
COMPLETED
Peer Support to Mitigate the Impact of Stigma in Young HIV+ Pregnant & Postpartum WomenNCT04036851 · lead sponsor · 2019-08-30
COMPLETED
Tenofovir-lamivudine-dolutegravir Combination as Second-line ART: a Randomised Controlled TrialNCT03991013 · lead sponsor · 2019-08-08
COMPLETED
Linezolid, Aspirin and Enhanced Dose Rifampicin in HIV-TBMNCT03927313 · lead sponsor · 2019-06-12
COMPLETED
Hypertension And Surgery Study: Evaluating the Implementation of a Hypertension Guideline ProtocolNCT03921086 · lead sponsor · 2019-01-14
COMPLETED
Study of Hip and Knee Arthroplasty in South AfricaNCT03540667 · lead sponsor · 2018-05-07
COMPLETED
Clinical Evaluation of Adjusted Doses of Darunavir/Ritonavir With Rifampicin in HIV-infected VolunteersNCT03892161 · lead sponsor · 2018-04-12
TERMINATED
Timing of Referral to Adherence Clubs for Antiretroviral TherapyNCT03199027 · lead sponsor · 2017-01-18
COMPLETED
Prevalence of Hypertensive Disease in Patients Presenting for Elective Surgery in the Western Cape, South AfricaNCT03157661 · lead sponsor · 2016-10-24
COMPLETED
Acid-Base and Point of Care Ultrasound in Severe PreeclampsiaNCT02721771 · lead sponsor · 2016-03-01
COMPLETED
The Impact of Obesity on Cardiac Function in PregnancyNCT02677558 · lead sponsor · 2016-01-01
COMPLETED
Postpartum Adherence Clubs for Antiretroviral TherapyNCT03200054 · lead sponsor · 2016-01-01
COMPLETED
iLink (Incentives for Linkage to ART) Study: A Mixed-methods Study to Improve Linkage to HIV CareNCT02440386 · lead sponsor · 2015-04-01
UNKNOWN
Collaborative Care for the Detection and Management of Depression Among Adults Receiving Antiretroviral Therapy in South AfricaNCT02407691 · lead sponsor · 2015-04-01
COMPLETED
Task Sharing for the Care of Severe Mental Disorders in a Low-income CountryNCT02308956 · lead sponsor · 2015-03-01
COMPLETED
Task Sharing Counseling Intervention by Community Health Workers for Prenatal Depression in South AfricaNCT01977326 · lead sponsor · 2013-10-01
COMPLETED
Pregnancy-Related Obesity Prevention Through Education & Communication Technology in AFRICA:The PROTECT-AFRICA STUDYNCT01948323 · lead sponsor · 2013-09-01
UNKNOWN
Preventing TB-IRIS in High-risk Patients: a Randomized Placebo-controlled Trial of PrednisoneNCT01924286 · lead sponsor · 2013-08-30
COMPLETED
Strategies to Optimize Antiretroviral Therapy Services for Maternal & Child Health: the MCH-ART StudyNCT01933477 · lead sponsor · 2013-03-01
COMPLETED
A Trial of the Urine LAM Strip Test for TB Diagnosis Amongst Hospitalized HIV-infected PatientsNCT01770730 · lead sponsor · 2013-01-01
COMPLETED
Bi Treatment With Hydralazine/Nitrates Versus Placebo in Africans Admitted With Acute Heart FailureNCT01822808 · lead sponsor · 2013-01-01
UNKNOWN
Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study)NCT01637558 · lead sponsor · 2012-11-01
COMPLETED
The Pan African Pulmonary Hypertension Cohort StudyNCT02265887 · lead sponsor · 2012-06-01
COMPLETED
Early Versus Delayed BCG Vaccination of HIV-exposed InfantsNCT02062580 · lead sponsor · 2010-06-01
COMPLETED
Typing of Human Papilloma Virus (HPV) From Female Genital WartsNCT01192282 · lead sponsor · 2010-04-01
COMPLETED
Utility of Sputum Induction and Novel Technologies to Improve TB Diagnosis in a High HIV Prevalence Primary Care SettingNCT01545661 · lead sponsor · 2009-08-01
COMPLETED
Pharmacokinetic Interaction Between the Antimalarial Combination Artemether/Lumefantrine and Combination Antiretroviral Therapy Including Lopinavir/Ritonavir in HIV-infected AdultsNCT00869700 · lead sponsor · 2009-06-01
COMPLETED
Artemether/Lumefantrine and Nevirapine Interaction Study in HIV-infected AdultsNCT00790881 · lead sponsor · 2008-10-01
COMPLETED
Impact of Employee Wellness ProgrammeNCT01625039 · lead sponsor · 2008-01-01
COMPLETED
Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected PersonsNCT00463086 · lead sponsor · 2007-11-01
COMPLETED
Isoniazid Prophylaxis With Concomitant Cotrimoxazole in HIV-infected ChildrenNCT00330304 · lead sponsor · 2003-01-01
COMPLETED
Implementing Depression and Adherence TreatmentNCT07032363 · collaborator · 2026-05-20
RECRUITING
Therapeutic Drug Monitoring for Linezolid in the Treatment of Rifampin-resistant TuberculosisNCT06590428 · collaborator · 2026-04-07
RECRUITING
Mentor Moms+ StudyNCT06962592 · collaborator · 2025-09-01
RECRUITING
Reducing Psychological Barriers to PrEP Persistence Among Pregnant and Postpartum Women in Cape Town, South AfricaNCT05624931 · collaborator · 2025-04-17
RECRUITING
Dolutegravir Pharmacokinetics During Weekly Rifapentine/Isoniazid for TB PreventionNCT06281834 · collaborator · 2024-11-15
RECRUITING
National Blood Pressure Screening in Children to Improve Paediatric Healthcare in South AfricaNCT05982847 · collaborator · 2024-04-01
RECRUITING
South Africa Smoking Cessation and Engagement in HIV/TB Care CareNCT05842161 · collaborator · 2024-03-12
RECRUITING
Bring BPaL2Me Trial Comparing Nurse-Led RR-TB Treatment to Physician-Led RR-TB TreatmentNCT05671718 · collaborator · 2023-09-04
RECRUITING
Dolutegravir Pharmacokinetics Among HIV/TB Coinfected Children Receiving Standard and High-dose RifampicinNCT05069688 · collaborator · 2023-07-07
RECRUITING
Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan AfricaNCT04975178 · collaborator · 2022-10-17
RECRUITING
Intervention Development for Syndemics Among PWH in SANCT06152003 · collaborator · 2026-09-15
NOT_YET_RECRUITING
Protecting Against HIV Vaccine Misinformation With Adolescent Girls and Young Women in South AfricaNCT06700447 · collaborator · 2025-07-24
ACTIVE_NOT_RECRUITING
TANDem-2: Closing the Gap to Interventions for TANDNCT06879665 · collaborator · 2025-07-15
ENROLLING_BY_INVITATION
ARCHERY - Artificial Intelligence Based Radiotherapy Treatment Planning for Cervical, Head and Neck and Prostate CancerNCT05653063 · collaborator · 2023-12-07
ACTIVE_NOT_RECRUITING
Ultra-Short Course Bedaquiline, Clofazimine, Pyrazinamide and Delamanid Versus Standard Therapy for Drug-Susceptible TuberculosisNCT05556746 · collaborator · 2023-11-24
ACTIVE_NOT_RECRUITING

Drugs studied in this sponsor's trials

25 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing University of Cape Town as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
placebo6
isoniazid4
rifampin3
artemether / lumefantrine2
dolutegravir2
dolutegravir 50 MG2
prednisone2
rifapentine2
placebo RxCUI 8375 · Lead sponsor in 5 linked trial(s) · 0 currently recruiting 6 trials isoniazid RxCUI 6038 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 4 trials rifampin RxCUI 9384 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting 3 trials artemether / lumefantrine RxCUI 282448 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials dolutegravir RxCUI 1433868 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting 2 trials dolutegravir 50 MG RxCUI 1433869 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials prednisone RxCUI 8640 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials rifapentine RxCUI 35617 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting 2 trials aspirin RxCUI 1191 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial azithromycin RxCUI 18631 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial dexamethasone RxCUI 3264 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial efavirenz RxCUI 195085 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial ethambutol RxCUI 4110 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial hydralazine RxCUI 5470 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial isosorbide dinitrate RxCUI 6058 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial levofloxacin RxCUI 82122 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial linezolid RxCUI 190376 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial lopinavir / ritonavir RxCUI 284640 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial nevirapine RxCUI 53654 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial nitazoxanide RxCUI 31819 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial placebo Oral Tablet RxCUI 375221 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting 1 trial pyrazinamide RxCUI 8987 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial tenofovir RxCUI 117466 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial tenofovir alafenamide RxCUI 1721603 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

collaborator77
lead sponsor45
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.